According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.
According to the researchers at the University of Pennsylvania, synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
According to the researchers at the University of Pennsylvania, synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo
According to a team led by UCLA in collaboration with scientists from Stanford and the University of Pennsylvania, has demonstrated that a synthetic IL-9 receptor allows cancer-fighting T cells to do their job without the use of chemo or radiation.
Before a patient can undergo T cell therapy designed to target cancerous tumors, the patient's entire immune system must be destroyed with chemotherapy or radiation. The toxic side effects are well known, including nausea, extreme fatigue and hair loss.